Update on the clinical management of diffuse large B-cell lymphoma
Christian Gisselbrecht et al.
The multi-cohort SCHOLAR-1 study of refractory aggressive DLBCL
New CLL treatments, the standard of care and the importance of clonal evolution
iwNHL 2016 highlights: CAR T-cell therapy, DLBCL and new technologies
The importance of recgonizing different DLBCL subtypes